Primary Job Title Cofounder Primary Organization 
Proteostasis Therapeutics
Location Greater Boston Area, United States, North America Regions East Coast, New England Gender Male
LinkedIn View on LinkedIn
Randall W. King MD, PhD is a Cofounder of Proteostasis Therapeutics and Associate Professor in the Department of Cell Biology at Harvard Medical School, where his laboratory develops novel chemical tools to study ubiquitin-dependent protein breakdown and uses high-throughput siRNA screening to identify new genes required for cancer cell division.
Prior to joining the faculty at Harvard Medical School, Dr. King was a fellow at the Institute of Chemistry and Cell Biology at Harvard, where he developed new approaches in chemical genetics, including instrumentation used for the synthesis and screening of arrayed split-pool chemical libraries. Dr.King co-founded the drug discovery company Kalypsys in 2001, and served on its science advisory board for four years.
He received an MD from Harvard Medical School after receiving a PhD from Mark Kirschner's laboratory at the University of California, San Francisco (UCSF). He received a B.A. degree in chemistry from Carleton College in 1987.
